Clinical Trial Update: Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing etoposide plus lobaplatin vs etoposide plus cisplatin in limited small-cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• etoposide + lobaplatin
• etoposide/cisplatin

Snippet

Sponsor: Guizhou Medical University | Conditions: Small-cell Lung Cancer | Phase 2 | Status: UNKNOWN